This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Levetiracetam-Induced Depression in a Healthy Adult

Lauren M. Wier, BS; Sandra B. Tavares, RN; Audrey R. Tyrka, MD, PhD; Lawrence H. Price, MD; and Linda L. Carpenter, MD

Published: July 14, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: It has been suggested that adding lamotrigine to an ongoing treatment with risperidone and clozapine might significantly increase the serum concentration of risperidone.1 However, lamotrigine is not known to inhibit the cytochrome P450 (CYP) enzymes CYP2D6 or CYP3A4, which are the major enzymes involved in the metabolism of risperidone.2

To extend the knowledge about this possible drug interaction, we performed a retrospective analysis on data obtained from our routine therapeutic drug monitoring database for risperidone and its active metabolite 9-hydroxyrisperidone.’ ‹’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 67

Quick Links: Depression (MDD)